Bio-Rad Laboratories Inc. (BIO.B) on Wednesday reported a third-quarter loss of $341.9 million, after reporting a profit in the same period a ...

The outlook for full year 2025 remains unchanged at flat to 1% currency-neutral revenue growth, consistent with the Q2 update. Margins guidance is also unchanged. Q3 reported a slight revenue and ...

The company doesn't seem like it will generate pops in key fundamentals anytime soon.

Investing.com - Bio-Rad Labs B (NYSE: BIOb) reported third quarter EPS of $2.26, $0.37 better than the analyst estimate of $1.89.

The firm is projecting a gradual recovery of the academic market in the face of ongoing funding uncertainties and a government shutdown.

The Model 422 electro-eluter is an electroelution cell for preparative recovery of biomolecules from agarose and acrylamide gels. The eluter combines with the tank and lid of the Mini Trans-Blot® cell ...

The TC20 automated cell counter counts mammalian cells in one simple step using its innovative auto-focus technology and sophisticated cell counting algorithm to produce accurate cell counts in less ...

The challenges facing biotechs amid the ongoing financial fallout have resulted in the winding down of one US biotech, Vor Bio, and job losses at a clutch of other firms. Cambridge, ...

(R to L) EY's Ricardo Vilanova, Lila Bioscience's Molly Gibson, Merck's Iya Khalil, Insitro's Mary Rozenman, and Gallop Oncology's Luba Greenwood at BIO 2025. When Google shook the foundations of the ...

His mother believes Halloween “brings out the devil,” so husband wants to keep their baby’s lion costume a secret. Fiancé’s “shallow” family will judge him if they find out the letter writer’s ...

Replay the call for the latest insights. Loading chart for INMB ...

Filmmaker Sterlin Harjo's new FX series, "The Lowdown," is a "Tulsa noir" filmed in his home state of Oklahoma. The show stars Ethan Hawke as a citizen journalist inspired by the late Tulsa ...